Table 3.
2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
No diabetes | |||||||||||
N | 424 | 479 | 589 | 652 | 766 | 835 | 1119 | 1257 | 1334 | 1379 | 8834 |
Incidence* | 4.07 | 4.82 | 5.16 | 6.06 | 6.43 | 8.4 | 9.44 | 9.75 | 10.07 | 7.12 | 6.9 |
Age, mean* (SD) | 72.08 (7.97) | 73.11 (7.75) | 72.55 (8.02) | 73.31 (7.51) | 73.56 (8.15) | 73.58 (7.74) | 73.65 (7.94) | 73.99 (7.86) | 73.85 (7.75) | 73.68 (7.7) | 73.51 (7.84) |
Male, n (%)* | 410 (96.7) | 458 (95.62) | 572 (97.11) | 631 (96.78) | 725 (94.65) | 792 (94.85) | 1052 (94.01) | 1191 (94.75) | 1261 (94.53) | 1299 (94.2) | 8391 (94.99) |
CCI 0–1, n (%) | 250 (58.96) | 240 (50.1) | 279 (47.37) | 348 (53.37) | 398 (51.96) | 417 (49.94) | 588 (52.55) | 635 (50.52) | 718 (53.82) | 732 (53.08) | 4605 (52.13) |
CCI 2, n (%) | 131 (30.9) | 163 (34.03) | 212 (35.99) | 216 (33.13) | 263 (34.33) | 303 (36.29) | 383 (34.23) | 455 (36.2) | 451 (33.81) | 453 (32.85) | 3030 (34.30) |
CCI ≥3, n (%) | 43 (10.14) | 76 (15.87) | 98 (16.64) | 88 (13.5) | 105 (13.71) | 115 (13.77) | 148 (13.23) | 167 (13.29) | 165 (12.37) | 194 (14.07) | 1190 (13.57) |
Smoking* | 151 (35.61) | 192 (40.08) | 222 (37.69) | 246 (37.73) | 288 (37.6) | 346 (41.44) | 451 (40.3) | 528 (42) | 562 (42.13) | 611 (44.31) | 3597 (40.72) |
LOSH, mean (SD)* | 8 (10) | 8 (9) | 8 (10) | 8 (7.5) | 8 (9) | 7 (8) | 7 (9) | 7 (7) | 6 (6) | 6 (6) | 7 (8) |
IHM, n (%) | 25 (5.9) | 38 (7.93) | 40 (6.79) | 49 (7.52) | 62 (8.09) | 59 (7.07) | 69 (6.17) | 89 (7.08) | 87 (6.52) | 83 (6.02) | 601 (6.80) |
Diabetes | |||||||||||
N | 51 | 63 | 86 | 104 | 109 | 166 | 209 | 262 | 258 | 243 | 1551 |
Incidence* | 2.14 | 2.64 | 3.46 | 4.02 | 4.21 | 5.88 | 7.06 | 8.85 | 7.66 | 7.21 | 5.55 |
Age, mean* (SD) | 72.88 (6.51) | 72.37 (7.79) | 72.36 (7.21) | 73.7 (6.61) | 72.39 (7.52) | 72.82 (7.54) | 73.24 (7.23) | 72.98 (7.34) | 73.69 (7.65) | 73.16 (7.65) | 73.09 (7.39) |
Male, n (%) | 49 (96.08) | 59 (93.65) | 86 | 103 (99.04) | 104 (95.41) | 161 (96.99) | 203 (97.13) | 257 (98.09) | 247 (95.74) | 233 (95.88) | 1502 (96.84) |
CCI 0–1, n (%)* | 21 (41.18) | 21 (33.33) | 41 (47.67) | 41 (39.42) | 47 (43.12) | 70 (42.17) | 89 (42.58) | 138 (52.67) | 124 (48.06) | 130 (53.5) | 722 (46.55) |
CCI 2, n (%) | 26 (50.98) | 30 (47.62) | 28 (32.56) | 42 (40.38) | 38 (34.86) | 59 (35.54) | 91 (43.54) | 95 (36.26) | 97 (37.6) | 75 (30.86) | 581 (37.46) |
CCI ≥3, n (%) | 4 (7.84) | 12 (19.05) | 17 (19.77) | 21 (20.19) | 24 (22.02) | 37 (22.29) | 29 (13.88) | 29 (11.07) | 37 (14.34) | 38 (15.64) | 248 (15.99) |
Smoking* | 18 (35.29) | 33 (52.38) | 34 (39.53) | 37 (35.58) | 34 (31.19) | 59 (35.54) | 100 (47.85) | 120 (45.8) | 109 (42.25) | 106 (43.62) | 650 (41.91) |
LOSH, mean (SD) | 9 (8) | 7 (7) | 8 (7) | 7 (8) | 8 (12) | 7 (6) | 7 (6) | 7 (8) | 7 (7) | 6 (6) | 7 (7) |
IHM, n (%) | 3 (5.88) | 6 (9.52) | 3 (3.49) | 9 (8.65) | 9 (8.26) | 11 (6.63) | 12 (5.74) | 11 (4.2) | 15 (5.81) | 12 (4.94) | 91 (5.87) |
N: Number of procedures; Incidence: per 100,000 inhabitants; LOHS: length of stay; IHM: In-hospital mortality; CCI (Charlson Comorbidity Index): Comorbidities included in the Charlson comorbidity index, except diabetes.*P < 0.05 (ANOVA or Kruskal-Wallis analysis) or (χ2 linear trend analysis).